genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Biohaven
GEN Edge
StockWatch: Short Seller Briefly Dents Apellis Shares
Alex Philippidis
-
September 29, 2023
0
Drug Discovery
“Bullish” Biopharma M&A Market Predicted for Closing Months of 2022
Alex Philippidis
-
August 9, 2022
0
Cancer
StockWatch: Biohaven, and Investors, Benefit from Pfizer Buying Spree
Alex Philippidis
-
May 13, 2022
0
Drug Discovery
Pfizer Adds Migraine Drugs with Planned $11.6B Biohaven Acquisition
Alex Philippidis
-
May 10, 2022
0
Scroll Up